PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2024 January; 15(1): e0005. ISSN: 2076-9172Published online 2024 January 19. doi: 10.5041/RMMJ.10519.

Table 2.

Family B: Demographics and Medical History of Affected Individuals.

Parameter	Subject Number
Parameter	II1	II2	II3	III1^*	III2^*	III3^*	III4^*	III5
Sex	F	F	F	M	F	F	M	F
Age at onset	36 yr	16 yr	5 yr	6 mo	6 mo	1 yr	6 mo	4 yr
Eye involved	RE	BE	RE	BE	RE	LE	BE	RE
Epiphora	Y	Y	Y	Y	Y	Y	Y	Y
Dacryocystitis	N	Y	N	N	N	N	N	N
Other ocular conditions	N	N	N	N	N	N	N	N
Topical eye treatment	Ofloxacin Dexamethasone	Ofloxacin Dexamethasone	N	N	N	N	N	N
Smoking	N	N	N	N	N	N	N	N
Other sinonasal disorders	N	N	N	N	N	N	N	N
Other systemic diseases	N	N	N	N	N	N	N	N
Treatment	LE:ENDO-DCR	LE:ENDO-DCR	Conservative	N	N	N	N	N
Comments	N	N	Down syndrome, CNLDO	Epiphora, CNLDO^*	Epiphora, CNLDO^*	Epiphora, CNLDO^*	Epiphora, CNLDO^*	Epiphora, CNLDO

BE, both eyes; CNLDO, congenital nasolacrimal duct obstruction; DES, dry eye syndrome; DM, diabetes mellitus; ENDO-DCR, endoscopic dacryocystorhinostomy; F, female; II, second generation; III, third generation; LE, left eye; M, male; mo, month; N, no; RE, right eye; Y, yes; yr, year.

^* Reported by parents, spontaneous resolution noted with age.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2024 January; 15(1): e0005. ISSN: 2076-9172

Published online 2024 January 19. doi: 10.5041/RMMJ.10519.